Glenmede Trust’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $62.7M | Sell |
521,378
-2,993
| -0.6% | -$346K | 0.31% | 70 |
|
|
2025
Q4 | $55.2M | Buy |
+524,371
| New | +$49.2M | 0.26% | 79 |
|
|
2025
Q1 | $64.7M | Buy |
720,348
+220,276
| +44% | +$20.6M | 0.35% | 68 |
|
|
2024
Q4 | $49.7M | Sell |
500,072
-598,169
| -54% | -$61.7M | 0.25% | 86 |
|
|
2024
Q3 | $125M | Buy |
1,098,241
+415,340
| +61% | +$49.3M | 0.6% | 33 |
|
|
2024
Q2 | $84.5M | Sell |
682,901
-8,274
| -1% | -$1.07M | 0.43% | 53 |
|
|
2024
Q1 | $91.2M | Sell |
691,175
-20,115
| -3% | -$2.48M | 0.46% | 49 |
|
|
2023
Q4 | $77.5M | Sell |
711,290
-239,929
| -25% | -$24.9M | 0.4% | 59 |
|
|
2023
Q3 | $97.9M | Sell |
951,219
-74,786
| -7% | -$8.06M | 0.56% | 36 |
|
|
2023
Q2 | $109M | Sell |
1,026,005
-302
| -0% | -$34.3K | 0.62% | 34 |
|
|
2023
Q1 | $109M | Buy |
1,026,307
+122,755
| +14% | +$13.3M | 0.62% | 34 |
|
|
2022
Q4 | $100M | Sell |
903,552
-38,783
| -4% | -$3.96M | 0.59% | 35 |
|
|
2022
Q3 | $81.2M | Buy |
942,335
+123,882
| +15% | +$11.1M | 0.51% | 42 |
|
|
2022
Q2 | $74.6M | Buy |
818,453
+15,501
| +2% | +$1.37M | 0.44% | 55 |
|
|
2022
Q1 | $65.9M | Sell |
802,952
-52,482
| -6% | -$4.14M | 0.32% | 84 |
|
|
2021
Q4 | $65.6M | Buy |
855,434
+32,545
| +4% | +$2.59M | 0.31% | 82 |
|
|
2021
Q3 | $61.8M | Buy |
822,889
+8,057
| +1% | +$613K | 0.32% | 84 |
|
|
2021
Q2 | $63.4M | Sell |
814,832
-375,024
| -32% | -$27.9M | 0.33% | 79 |
|
|
2021
Q1 | $87.5M | Sell |
1,189,856
-196,086
| -14% | -$14.5M | 0.47% | 49 |
|
|
2020
Q4 | $108M | Sell |
1,385,942
-91,221
| -6% | -$6.98M | 0.59% | 33 |
|
|
2020
Q3 | $117M | Sell |
1,477,163
-8,402
| -0.6% | -$658K | 0.7% | 24 |
|
|
2020
Q2 | $110M | Sell |
1,485,565
-471,268
| -24% | -$35.5M | 0.67% | 31 |
|
|
2020
Q1 | $170M | Hold |
1,956,833
| – | – | 0.77% | 24 |
|
|
2019
Q4 | $170M | Sell |
1,956,833
-213,474
| -10% | -$17.5M | 0.77% | 24 |
|
|
2019
Q3 | $174K | Buy |
2,170,307
+660,592
| +44% | +$52.9M | 0.8% | 17 |
|
|
2019
Q2 | $121K | Buy |
1,509,715
+383,594
| +34% | +$29.4M | 0.53% | 42 |
|
|
2019
Q1 | $89.4K | Buy |
1,126,121
+10,513
| +0.9% | +$786K | 0.4% | 57 |
|
|
2018
Q4 | $81.3K | Sell |
1,115,608
-8,652
| -0.8% | -$611K | 0.4% | 58 |
|
|
2018
Q3 | $76.1M | Sell |
1,124,260
-3,709
| -0.3% | -$236K | 0.3% | 74 |
|
|
2018
Q2 | $65.3M | Sell |
1,127,969
-1,186,849
| -51% | -$67M | 0.29% | 83 |
|
|
2018
Q1 | $124M | Hold |
2,314,818
| – | – | 0.52% | 40 |
|
|
2017
Q4 | $124M | Sell |
2,314,818
-473,595
| -17% | -$26.3M | 0.52% | 40 |
|
|
2017
Q3 | $170M | Sell |
2,788,413
-1,117,413
| -29% | -$67.7M | 0.75% | 14 |
|
|
2017
Q2 | $237M | Hold |
3,905,826
| – | – | 1.13% | 4 |
|
|
2017
Q1 | $237M | Buy |
3,905,826
+1,327,845
| +52% | +$80.6M | 1.13% | 4 |
|
|
2016
Q4 | $145M | Buy |
2,577,981
+25,331
| +1% | +$1.48M | 0.79% | 12 |
|
|
2016
Q3 | $152M | Buy |
2,552,650
+531,910
| +26% | +$31.1M | 0.86% | 10 |
|
|
2016
Q2 | $111M | Buy |
2,020,740
+7,931
| +0.4% | +$422K | 0.67% | 19 |
|
|
2016
Q1 | $102M | Sell |
2,012,809
-92,240
| -4% | -$4.52M | 0.66% | 20 |
|
|
2015
Q4 | $106M | Buy |
2,105,049
+740,288
| +54% | +$37.3M | 0.72% | 16 |
|
|
2015
Q3 | $64.3M | Buy |
1,364,761
+66,450
| +5% | +$3.53M | 0.47% | 41 |
|
|
2015
Q2 | $70.5M | Sell |
1,298,311
-25,136
| -2% | -$1.41M | 0.51% | 38 |
|
|
2015
Q1 | $72.6M | Buy |
1,323,447
+62,947
| +5% | +$3.56M | 0.53% | 29 |
|
|
2014
Q4 | $68.3M | Buy |
1,260,500
+2,795
| +0.2% | +$156K | 0.54% | 30 |
|
|
2014
Q3 | $71.1M | Buy |
1,257,705
+2,153
| +0.2% | +$121K | 0.62% | 24 |
|
|
2014
Q2 | $69.3M | Buy |
1,255,552
+10,016
| +0.8% | +$546K | 0.62% | 29 |
|
|
2014
Q1 | $67.5M | Sell |
1,245,536
-11,818
| -0.9% | -$612K | 0.63% | 30 |
|
|
2013
Q4 | $60M | Sell |
1,257,354
-19,805
| -2% | -$905K | 0.61% | 32 |
|
|
2013
Q3 | $58M | Sell |
1,277,159
-2,374
| -0.2% | -$108K | 0.69% | 30 |
|
|
2013
Q2 | $56.7M | Buy |
+1,279,533
| New | +$57.1M | 0.71% | 30 |
|
Other funds holding MRK
VCM
VPM
Glenmede Trust's MRK Position: Q1 2026 in Review
Glenmede Trust reduced its Merck (MRK) stake by 0.57% in Q1 2026, selling an estimated $346K and leaving 521,378 shares worth $62.7M. The position accounts for 0.31% of the portfolio, ranked #70.
Glenmede Trust first reported a position in MRK in Q2 2013 and has held it in 50 quarters since. The position peaked at $237M in Q2 2017. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Glenmede Trust held 521,378 shares of Merck worth $62.7M as of Q1 2026.
- Glenmede Trust sold 2,993 Merck shares in Q1 2026, an estimated $346K.
- Merck made up 0.31% of Glenmede Trust's portfolio in Q1 2026, its #70 holding.
- Glenmede Trust first reported a position in Merck in Q2 2013 and has held it in 50 quarters since.
- Glenmede Trust's Merck position peaked at $237M in Q2 2017.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.